Ondine Biomedical (LON:OBI) Trading Down 7.9% – Here’s What Happened

Ondine Biomedical Inc. (LON:OBI)’s stock price was down 7.9% during trading on Tuesday . The company traded as low as C$12.00 and last traded at C$12.25. Approximately 53,936 shares traded hands during mid-day trading, a decline of 87% from the average daily volume of 429,282 shares. The stock had previously closed at C$13.30.

Ondine Biomedical Stock Down 7.9 %

The company has a debt-to-equity ratio of 1,847.37, a current ratio of 0.80 and a quick ratio of 8.26. The firm’s 50 day moving average price is C$9.73 and its two-hundred day moving average price is C$8.16. The firm has a market cap of C$3.40 billion, a price-to-earnings ratio of -408.33 and a beta of 0.10.

Insiders Place Their Bets

In other news, insider Carolyn Cross bought 200,775 shares of Ondine Biomedical stock in a transaction dated Thursday, January 30th. The stock was bought at an average price of C$12.00 per share, for a total transaction of C$2,409,300.00. 36.69% of the stock is owned by insiders.

About Ondine Biomedical

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.

Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.